BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Nefopam

the relief of acute and chronic pain. (From Martindale, The Extra Pharmacopoeia, 30th ed, p26)

299+ PubMed studies analyzed · 83 RCTs · Evidence Score: 56.6

Research Domains

Nefopam has been studied across 15 research domains including 💊 Pain, 😴 Sleep, 🌤️ Mood & Depression, 🧠 Focus & Attention, 🔬 Oncology. The primary research focus is 💊 Pain with 75% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Nefopam, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Aprindine
7 shared targets
desloratadine
9 shared targets
Nebivolol
9 shared targets
methapyrilene
8 shared targets
Encainide
5 shared targets
Chlorpheniramine
9 shared targets
orphenadrine
9 shared targets
citalopram
7 shared targets
protriptyline
11 shared targets
dexchlorpheniramine
8 shared targets
Loading evidence profile...

This evidence profile for Nefopam is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.